↓ Skip to main content

Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy

Overview of attention for article published in Drugs, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
3 news outlets
twitter
4 X users
patent
2 patents

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy
Published in
Drugs, January 2020
DOI 10.1007/s40265-019-01249-z
Pubmed ID
Authors

Alexander C. Cohen, Brandon M. Roane, Charles A. Leath

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Other 7 10%
Student > Bachelor 7 10%
Student > Master 6 8%
Student > Postgraduate 5 7%
Student > Ph. D. Student 3 4%
Other 8 11%
Unknown 36 50%
Readers by discipline Count As %
Medicine and Dentistry 15 21%
Biochemistry, Genetics and Molecular Biology 6 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Agricultural and Biological Sciences 3 4%
Arts and Humanities 1 1%
Other 5 7%
Unknown 39 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2023.
All research outputs
#1,521,488
of 25,813,008 outputs
Outputs from Drugs
#147
of 3,486 outputs
Outputs of similar age
#37,190
of 481,376 outputs
Outputs of similar age from Drugs
#6
of 32 outputs
Altmetric has tracked 25,813,008 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,486 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.